Papers

2

Total Citations

133

H-Index

2

About

Gonzalo Labarca is a leading pulmonary researcher whose work centers on advancing the diagnosis of peripheral pulmonary lesions. His major contributions lie in evaluating and comparing the accuracy and safety of cutting-edge bronchoscopic techniques against traditional methods. In a landmark 2022 study (91 citations), he demonstrated that robotic-assisted bronchoscopy offers a compelling alternative to CT-guided transthoracic biopsy, a critical finding for reducing procedural risks. Building on this, his comprehensive 2024 network meta-analysis (42 citations) synthesized global data to clarify the optimal diagnostic modality, providing crucial evidence for clinical decision-making. By systematically comparing bronchoscopic approaches with CT-guided biopsies, Labarca has helped define the modern diagnostic algorithm for lung nodules. His work is highly influential, guiding pulmonologists toward safer, more effective strategies for early lung cancer detection. Through rigorous meta-analyses and comparative effectiveness research, Labarca has established himself as a key voice in the evolution of interventional pulmonology, directly shaping how clinicians approach the diagnosis of suspicious lung lesions.

Research Focus

Key Achievements

2
H-Index
2
Papers
133
Total Citations
67
Avg Citations/Paper
🏆 Most Cited Paper
<scp>Robotic‐assisted</scp> bronchoscopy versus <scp>CT</scp>‐guided transthoracic biopsy for diagnosis of pulmonary nodules
91 citations · 2022
📈 Most Prolific Year: 2022 (1 Papers)
🤝 Key Collaborators: 16
🏛 Institutions: Brigham and Women's Hospital, Beth Israel Deaconess Medical Center

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 14 days ago